Phibro Animal Health Corporation $PAHC Stock Holdings Increased by Profund Advisors LLC

Profund Advisors LLC grew its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 229.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,263 shares of the company’s stock after acquiring an additional 18,291 shares during the period. Profund Advisors LLC owned 0.06% of Phibro Animal Health worth $939,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Ranger Investment Management L.P. bought a new position in shares of Phibro Animal Health during the 2nd quarter valued at $9,182,000. Globeflex Capital L P acquired a new stake in shares of Phibro Animal Health in the 2nd quarter valued at $5,942,000. Allspring Global Investments Holdings LLC lifted its stake in shares of Phibro Animal Health by 145.5% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 286,172 shares of the company’s stock valued at $15,671,000 after purchasing an additional 169,628 shares during the last quarter. Castleark Management LLC bought a new stake in Phibro Animal Health in the first quarter worth $7,904,000. Finally, Cvfg LLC bought a new stake in Phibro Animal Health in the first quarter worth $2,962,000. 99.34% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. Weiss Ratings raised Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $47.67.

Phibro Animal Health Stock Down 2.8%

Shares of Phibro Animal Health stock opened at $37.65 on Wednesday. Phibro Animal Health Corporation has a 12-month low of $28.25 and a 12-month high of $60.08. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84. The stock has a 50 day moving average price of $37.09 and a two-hundred day moving average price of $41.10. The stock has a market capitalization of $1.53 billion, a P/E ratio of 12.07 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.14. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. The company had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Equities analysts expect that Phibro Animal Health Corporation will post 3.49 earnings per share for the current year.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.